How much does Breyanzi (lisocabtagene maraleucel) cost in the US?
Breyanzi is a CAR-T cell therapy, and its total cost is typically discussed as the combination of the drug price plus treatment and hospital costs (especially for leukapheresis, lymphodepleting chemotherapy, and inpatient/outpatient CAR-T administration). Exact totals vary by insurance coverage, site of care, and patient-specific care pathways, so there isn’t one universal “Breyanzi cost” figure that applies to every patient.
What is the list price of Breyanzi?
Information about Breyanzi’s list price is often reported for the drug itself, but the final patient cost depends heavily on insurance and negotiated rates. Without a specified pricing year or source, I can’t give a single definitive number.
How much will patients pay out of pocket?
Out-of-pocket costs depend on:
- Insurance type (commercial vs. Medicare vs. Medicaid)
- Whether the insurer covers CAR-T under medical benefits vs. pharmacy benefits
- Deductibles, copays, and coinsurance
- Prior authorization and treatment setting
- Any manufacturer assistance programs or financial support (if applicable in the patient’s situation)
Does insurance coverage affect the cost more than the drug price?
Usually, yes. For high-cost therapies like CAR-T, negotiated contracts and coverage decisions can determine whether the patient pays little, a moderate amount, or a substantial share. Even when the drug price is the same, the billed and allowed amounts can differ widely.
Can I lower the cost through patient assistance or copay support?
Potential options may include manufacturer assistance (when eligibility rules are met) and specialty pharmacy or reimbursement support programs. Whether a patient qualifies depends on factors like insurance status, income, and residency.
What costs are included beyond the Breyanzi product?
Breyanzi treatment commonly involves costs beyond the medication itself, such as:
- Collection (leukapheresis)
- Bridging therapy (if needed)
- Lymphodepleting chemotherapy
- Hospital/clinic administration and monitoring
- Management of side effects and CAR-T complications (for example, cytokine release syndrome or neurologic events)
What if you’re comparing Breyanzi cost vs other CAR-T options?
Patients often compare Breyanzi against other CAR-T therapies based on:
- Coverage and prior authorization likelihood
- Site-of-care experience and required infrastructure
- Total care pathway costs, not just the drug price
If you tell me your details, I can help estimate the “total cost” range
If you share:
1) Country (and state if US)
2) Insurance type (commercial / Medicare / Medicaid / uninsured)
3) Whether you have an authorization/benefits determination yet
4) Treatment setting (inpatient vs outpatient CAR-T center)
…I can help you narrow down what “Breyanzi cost” likely means for your situation (drug price, billed medical costs, and potential out-of-pocket range).